Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

H. Mu



Author of

  • +

    P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC (ID 206)

    • Event: WCLC 2015
    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 1
    • +

      P1.01-036 - RFA for Palliative Treatment of NSCLC Rib Painful Metastasis: Experience in 12 Patients (ID 312)

      09:30 - 09:30  |  Author(s): H. Mu

      • Abstract
      • Slides

      Background:
      Painful rib metastasis is common in NSCLC. Pain sometimes was partially or totally refractory to analgesic medications or the side-effects of medication were unacceptable. We report the safety and efficacy of a new method: radiofrequency ablation in treating painful none small cell lung cancer (NSCLC) rib metastasis.

      Methods:
      treating painful none small cell lung cancer (NSCLC) rib metastasis. Methods radiofrequency ablation procedures were completed in 12 patients with painful rib metastasis. Patient age ranged from 66 to 83 years (mean 74.8 years, Standard Deviation (SD) =5.3).Pathology: squamous-carcinoma 4 cases, adeno-carcinoma 7 cases and large cell carcinoma 1 case. Pain causing neoplasm size, pain levels pre- and post-procedure (as assessed using the Visual Analog Scale), time length and target temperature of radiofrequency ablation (RFA) treatments were documented. Figure 1



      Results:
      Radiofrequency ablation (RFA) procedures were performed with 100% technical success. The mean pre-procedure and post-procedure pain, as measured by the Visual Analog Scale (VAS), was 7.9 (SD=0.90) and 3.4 (SD=0.99) respectively. No symptomatic complications occurred. Non-symptomatic complications included 1 case of pneumothorax, 1case of hemoptysis.

      Conclusion:
      RFA appears to be safe, practical and effective in the palliative treatment of none small cell lung cancer (NSCLC) chest wall painful metastasis.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • +

    P3.02 - Poster Session/ Treatment of Localized Disease – NSCLC (ID 211)

    • Event: WCLC 2015
    • Type: Poster
    • Track: Treatment of Localized Disease - NSCLC
    • Presentations: 1
    • +

      P3.02-013 - Preoperative CT-Guided Percutaneous Localization of GGO with PA Injection (ID 313)

      09:30 - 09:30  |  Author(s): H. Mu

      • Abstract

      Background:
      Localization of ground glass nodule is a difficult challenge for thoracic surgeons, especially for those GGOs less than 10 mm in diameter. In this study we implant a new method for Preoperative localization of ground glass pulmonary opacity (GGO).

      Methods:
      From October 2013 to December 2014, CT-guided percutaneous Polylactic acid injection localizations were performed for 5 pulmonary nodules in 5 patients (2 men and 3 women; mean age, 59.8 years; range, 54-65 years). Figure 1



      Results:
      The injection was feasible in all patients and the localization effect was excellent, with total procedure duration 12.6 minutes (range; 10-15), Volume of Polylactic acid injected 0.38ml (Table 2). The wedge resections were easily and successfully performed in 5 cases, the cutting margin was no less than 2cm from lesion.

      Conclusion:
      This technique will be promising for GGO location in facilitating thoracoscopic surgery for wedge resection.